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Background: Physicians treating patients in the vegetative state (VS) must deal with uncertainty in diagnosis and
prognosis, as well as ethical issues. We examined whether physicians’ attitudes toward medical and ethical
challenges vary across two national medical practice settings.
Methods: A comparative survey was conducted among German and Canadian specialty physicians, based on a
case vignette about the VS. Similarities and differences of participants’ attitudes toward medical and ethical
challenges between the two samples were analyzed with non-parametric tests (Mann-Whitney-U-Test).
Results: The overall response rate was 13.4%. Eighty percent of all participants correctly applied the diagnostic
category of VS with no significant differences between countries. Many of the participants who chose the correct
diagnosis of VS attributed capabilities to the patient, particularly the ability to feel pain (70%), touch (51%) and to
experience hunger and thirst (35%). A large majority of participants (94%) considered the limitation of life-sustaining
treatment (LST) under certain circumstances, but more Canadian participants were in favor of always limiting LST
(32% vs. 12%; Chi-square: p < 0.001). Finding long-term care placement was considered more challenging by
Canadian participants whereas discontinuing LST was much more challenging for German participants.
Conclusions: Differences were found between two national medical practice settings with respect to physicians’
experiences and attitudes about treatment limitation about VS in spite of comparable diagnostic knowledge.
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In the last decade the development of diagnostic criteria for
disorders of consciousness, particularly the vegetative state
(VS, or UWS: unresponsive wakefulness syndrome [1]) and
the minimally conscious state (MCS) [2], has reflected a
more advanced understanding of impaired responsiveness
and awareness following brain injury. Diagnostic guidelines
remain largely based on the observation of the patient’s be-
havior: a patient in a VS shows wakefulness without behav-
ioral signs of awareness, such as meaningful reaction to* Correspondence: eric.racine@ircm.qc.ca
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distribution, and reproduction in any mediumstimuli, whereas a patient in a MCS shows intermittent be-
havioral signs for awareness, but is incapable of reliable
communication [3,4].
Disorders of consciousness are often misdiagnosed
[5-8] and cases of “miraculous” late recovery have ques-
tioned timelines for determining the irreversibility of the
VS [9-11]. Surveys of physicians’ attitudes toward end-
of-life decisions and publically discussed legal cases of
decisions about withdrawal of artificial nutrition and hy-
dration have shown considerable diversity in attitudes
among different healthcare professions and countries
[12-17]. To further our understanding of the nature and
causes of this diversity with respect to attitudes towards
VS and decisions about the limitation of life-sustaining
treatment (LST), we undertook a bilateral survey amongntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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physicians’ understanding of the VS and elicited their atti-
tudes towards end-of-life issues in two different national
medical practice settings. Parts of the survey completed by
German neurologists have been previously reported [18].
In this paper, we focus on the comparison between the at-
titudes of German and Canadian physicians.
Methods
Study design
A self-administered questionnaire survey enabled us to tar-
get large groups of physicians. In Germany the question-
naire was distributed by e-mail. In Canada, it was converted
into a paper-based questionnaire because the emailed sur-
vey did not generate sufficient participation (n = 27).
The data were gathered anonymously and participants
gave their informed consent. To encourage participation
the participants of the German survey were offered an
opportunity to take part in a lottery, consisting of six
prizes with a total value of € 1500. After three weeks, we
sent a reminder and prolonged the participation eligibil-
ity period for an additional week. To encourage partici-
pation in the Canadian survey, two postcard reminders
were sent following the initial invitation.
The study was approved in Canada by the research ethics
board of the Institut de recherches cliniques de Montréal,
and in Germany by the research ethics committee of the
medical faculty at the University of Munich.
Participants
To include a representative cohort of German neurolo-
gists, we contacted the German Society for Neurology,
which facilitated the distribution of the survey link. Out
of 6673 members, we contacted all 3073 members for
whom the society had valid e-mail addresses and invited
only physicians to participate.
In the Canadian survey, questionnaires were mailed to
participants in their preferred language of correspondence
(French or English) as listed in Scott’s Medical Directory.
Neurologists, neurosurgeons, emergency medicine and
critical care physicians, and physical medicine and re-
habilitation specialists registered with the Royal College of
Physicians and Surgeons of Canada were included in the
cohort. We mailed surveys to 2085 participants.
Questionnaire
We developed a 37-item questionnaire that was in-
formed by the literature and a previous qualitative study
and our study goals [19]. The first part was a case vi-
gnette about a patient in the VS (1).
A 33-year-old man had a cardiac arrest with delayed
resuscitation 4 months ago. Currently, he shows brain-
stem and spinal reflex movements, but no sign of pur-
poseful movement. His eyes are open for several hours aday, but do not fixate objects or follow them when they
move. He does not react consistently* to verbal com-
mands or questions. Sometimes a delayed stiffening of
the legs and grimacing can be observed in reaction to
sounds. He can breathe on his own.
In response to the results and comments from the German
online survey, the wording of the case was slightly modi-
fied in the Canadian print survey. To reduce ambiguity,
the sentence “He does not react consistently to verbal
commands or questions” was changed to “He does not
react to verbal commands or questions”. For detailed in-
formation on the questionnaire development and content
see our previous publication [7]. The questionnaire was
translated from English into German and French using
backward-forward-translation by native speakers. The
German data were gathered within a four-week period
from July to August 2011, the Canadian data were gath-
ered within a four-month period from January to May
2012 for the postal survey.
Statistical analysis
Data from the paper version of the survey were imported
into IBM SPSS 19 statistics software. Pearson’s chi-square
test was performed to assess differences between categor-
ies. For numerical or ordinal data the Mann-Whitney-U-
Test was applied to compare two groups. Results were
considered significant if p < 0.05. P-values are descriptive
and were not adjusted for multiple comparisons. The
study was powered to detect a 15% difference in the atti-
tudes towards limiting LST between the two countries
with a probability of 80%. Participants who failed to cor-
rectly diagnose the patient in the case vignette were ex-
cluded from further analysis of their attitudes, as it was
unclear whether they answered the remaining questions




The demographic and professional characteristics of the
participants in both samples are presented in Table 1. Of
the 3073 professionals who were contacted in the German
survey, one third (n = 1024) was randomly assigned to re-
ceive the VS case. Out of these, 168 participants (16.4%)
completed a questionnaire according to the VS case. The
cohort of 3073 members of the German Society for Neur-
ology was representative for all members (N = 6673) ac-
cording to age (members: mean 44, standard deviation
(SD) 10, range 25–94, and cohort: mean 45, SD 9, range
25–87) and region of practice, but not gender. A lower
percentage of women was invited to participate (28%) than
the actual percentage of women in the Society (38%). The
sample was representative for the Society according to age
(mean 43, SD 9, range 27–80).
Table 1 Demographic and professional characteristics of participants (n = 417)
Variable Canadian sample (n = 249) German sample (n = 168)
No. (%)
Gender (n = 395)
Female 63 (27) 47 (30)
Male 175 (74) 110 (70)
Primary discipline*
Neurology 114 (46) 161 (96)
Neurosurgery 41 (17) 1 (1)
Rehabilitation medicine 42 (17) 20 (12)
Emergency medicine 35 (14) - -
Others (e.g., anesthesiology) 10 (4) 20 (12)
Health care setting*
In-patient care 185 (74) 115 (69)
Out-patient care 197 (79) 62 (37)
Type of care*
Acute care 159 (64) 71 (42)
Rehabilitation care 47 (19) 36 (21)
Long-term care 26 (10) 17 (10)
Professional experience with patients in the VS (n = 383)
0 cases 28 (13) 2 (1)
1-10 cases 123 (55) 94 (60)
> 20 cases 73 (33) 63 (40)
Religious practice (n = 398)
Practicing religion 99 (41) 92 (58)
Not practicing religion 141 (59) 66 (42)
Spiritual beliefs (n = 392)
Spiritual beliefs 132 (56) 100 (64)
No spiritual beliefs 104 (44) 56 (36)
Median; 1st, 3rd quartile (range)
Age (years) 53; 41,59 (30 – 81) 43; 37,48 (27 – 80)
Experience (years) 21; 9,30 (<1 – 56) 15; 10;22 (2 – 51)
*Multiple answers permitted.
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vey, 249 physicians (11.9%) completed and returned the
questionnaire. Twelve declined to participate, 10 of them
indicating that they were not working with patients in the
VS. The sample was representative for the cohort accord-
ing to gender and language. Almost the same percentage
of women contacted (n = 564, 27%) responded to the sur-
vey (n = 63, 25%). The majority of participants filled out
the English version of the questionnaire (n = 192, 77%),
while one fifth returned the French version (n = 57, 23%),
which matched the distribution of English and French
questionnaires (English: n = 1659, 80%; French: n = 426,
20%). Among neurologists, the response rate was slightly
higher than in the cohort (46% compared to 39%). A com-
parable percentage of physical medicine and rehabilitationspecialists and neurosurgeons responded (specific re-
sponse rate 17% compared to 18% in the cohort; and 16%
compared to 13% in the cohort respectively). A lower per-
centage of critical care and emergency medicine specialists
(specific response rate 14% compared to 30% in the co-
hort) returned the survey.
Application of diagnostic knowledge
Overall 80% (n = 332) of all participants (n = 417) cor-
rectly chose the diagnostic category of VS for the patient
in the case vignette. In both samples a similar proportion
chose the correct diagnostic category (80% in Canada,
79% in Germany; p = 0.66). A comparison between the
neurologists in both samples showed analogous results:
82% of the Canadian neurologists (n = 115) compared to
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the correct diagnostic category to the case vignette (Chi-
square-test: p = 0.56). The Canadian participants who
received the original case vignette in the online survey
(n = 27) and those who received the slightly edited case
vignette in the paper and pencil survey (n = 222) did not
differ significantly in their accuracy rate (81% vs. 78%,
Chi-square test: p = 0.73). In both countries a comparable
proportion suggested an erroneous diagnosis of MCS for
the patient (18% in German and 15% in the Canadian
sample). Only a few respondents chose the diagnoses of
locked-in-syndrome (2% vs. 1% in the Canadian sample),
coma (1% vs. 2% in the Canadian sample), brain death
(none vs. 1% in the Canadian sample), or others (e.g., 1%
suggesting the patient is in different conditions at the
same time).
Most participants expressed a high degree of certainty of
their diagnosis (median = 8; 1st quartile = 6; 3rd quartile = 9
on a NRS (0-10)), regardless of correct (87%) or incorrect
(70%) diagnosis. Canadian and German participants did not
differ significantly in their level of certainty (p = 0.71).
We continued our data analysis with the participants
who accurately applied the diagnostic knowledge to the
case (hereafter referred to as “all groups” = all partici-
pants who applied the correct diagnostic knowledge;Table 2 Prognosis of survival and estimation of the patient’s
All C
Groups (n = 332) gro
Prognosis of survival (n = 329)
None (0%) 1 (0.3)
Minimal (<10%) 7 (2)
Very small (10-25%) 18 (6)
Small (26-50%) 42 (13)
Good (51-75%) 122 (37)
Very good (76-90%) 95 (29)
Excellent (>91%) 30 (9)
Certain (100%) 2 (1)
Not able to rate 12 (4)
Estimation of the patients quality of life (QoL) (n = 327)
No QoL 109 (33)






Not able to rate 44 (14)
QoL = Quality of life.“Canadian group” = all participants in the Canadian sam-
ple who applied the correct knowledge; and “German
group” = all participants in the German sample who ap-
plied the correct diagnostic knowledge).Prognosis and quality of life
Most of the participants estimated the prognosis of the pa-
tient’s survival under continuous medical support during
the next 6 months to be favorable with a majority predict-
ing good or very good chances for survival (See Table 2)
but opinions of Canadian and German physicians showed a
different distribution. Assessments of quality of life also dif-
fered between the two groups of physicians. Canadian phy-
sicians formulated bleaker assessments of quality of life
than their German counterpart who also more frequently
responded not being able to rate quality of life.Assessment of the patient’s capabilities
Although having diagnosed the patient in the case vi-
gnette as VS, participants attributed residual capabilities
to VS patients such as feeling pain, feeling touch, experi-
encing hunger/thirst, smelling odors, and tasting flavors of
food/drinks (see Table 3). More German than Canadian
participants attributed such capabilities to VS patients.quality of life
No. (%)
anadian German p value
up (n = 200) group (n = 132)
p = 0.049
1 (1) -
5 (3) 2 (2)
9 (5) 9 (7)
24 (12) 18 (14)
67 (34) 55 (42)
57 (29) 38 (29)
27 (14) 3 (2)
- 2 (2)
8 (4) 4 (3)
p < 0.001
91 (46) 18 (14)
58 (29) 33 (25)
28 (14) 18 (14)
11 (6) 19 (15)
2 (1) 3 (2)
- 2 (2)
- -
7 (4) 37 (29)
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The Canadian participants were more likely to favor limit-
ing LST than the German participants (see Figure 1). The
willingness to limit LST in specific circumstances (e.g., pa-
tient’s will is opposed to LST; patient suffers from fatal
disease; surrogate refuses consent to LST; no chance of re-
covery of consciousness; no improvement > 1 year) varied
considerably (see Additional file 1: Table S1). However,
there was a trend: Canadian participants were more likely
than German participants to favor the limitation of LST in
almost all circumstances.
Treatment measures
The willingness to limit specific life-sustaining treatment
measures showed a similar pattern in both samples.
Overall, 86% would limit cardiopulmonary resuscitation,
and the same percentage would do so with regard to in-
tubation and mechanical ventilation. The limitation of
hemodialysis and hemofiltration was considered by 80%;
the performance of a surgery by 65%. Antibiotic treatment
would be limited by 44%, artificial nutrition by 37% and
artificial hydration by 30%.
Although there were several differences between the
Canadian and the German group in the participants’ atti-
tudes towards treatment limitation, there was only oneTable 3 Attribution of capabilities of the patient in the veget
Agreement
All groups Cana
(n = 332)1 grou
(n = 2
Feeling pain 232 (70) 130
Feeling touch 168 (51) 79 (
Experiencing hunger/thirst 117 (35) 57 (
Smelling odors 94 (28) 48 (
Tasting flavors of food/drinks 69 (21) 31 (
Experiencing dreams 70 (21) 23 (
Having emotions 63 (19) 17
Having thoughts 48 (15) 18
Being aware of themselves 24 (7) 12
Recognizing their name 23 (7) 8 (
Recognizing people 23 (7) 6 (
Remembering experiences 22 (7) 5 (
Being aware of surroundings 20 (6) 12
Having sexual desires 19 (6) 2 (
Understanding what others say 16 (5) 5 (
Storing new information 14 (4) 4 (
Interacting with others 14 (4) 3 (
Expressing desires 5 (2) 2 (
1 Those who correctly diagnosed the patient; when expected frequencies in the res
*D (%) = Difference (% German group –% Canadian group).statistically significant difference in their attitudes to-
wards the limitation of specific treatment measures: 36%
of Canadian participants, compared to 23% of German
participants (p < 0.05) were willing to limit artificial
hydration.
Appraisal of ethical challenges
The appraisal of previously identified ethical challenges
is displayed in Table 4 (e.g., determining patient’s wishes;
accompanying family members in decisions; finding
long-term care; making prognosis and predicting recov-
ery). All such challenges were ranked differently in the
two samples.
Discussion
This study aimed to assess similarities and differences in
Canadian and German specialty physicians’ medical
knowledge of the VS and attitudes toward ethical chal-
lenges in this disorder. This was the first such survey in-
volving Canadian physicians. We found nearly identical
rates of 80% for diagnostic accuracy in both samples and
the subsamples of neurologists did not show greater ac-
curacy rates than other physicians. Participants in both
countries attributed a range of capabilities to patients in
VS. The majority considered acceptable to limit life-ative state
No. (%)
dian German D (%)* p value
p1 group1
00) (n = 132)
(65) 102 (77) (12) p = 0.017
40) 89 (67) (27) p < 0.001
29) 60 (46) (17) p = 0.002
24) 46 (35) (11) p = 0.032
16) 38 (29) (13) p = 0.003
12) 47 (36) (24) p < 0.001
(9) 46 (35) (26) p < 0.001
(9) 30 (23) (14) p < 0.001
(6) 12 (9) (3) p = 0.287
4) 16 (12) (8) p = 0.005
3) 17 (13) (10) p = 0.001
3) 17 (13) (10) p < 0.001
(6) 8 (6) (0) p = 0.982
1) 17 (13) (12) p < 0.001
3) 11 (8) (5) p = 0.015
2) 10 (8) (6) p = 0.013
2) 11 (8) (6) p = 0.002
1) 3 (2) (1) -




















Canadian group German group
*
Figure 1 Attitudes towards the limitation of LST. Attitudes of participants who assigned the correct diagnosis to the vignette towards the
question: “In the prior case life-sustaining treatment should be limited…?” Overall the differences between the two groups were significant
(Chi-square test: p < 0.001). N = 332, Canadian group (N = 195), German group (N = 131); Missing data: 6; numbers may not add up to 100 due
to rounding.
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ever, participants’ appraisals of ethical challenges differed
between the countries.
Our findings indicate lower inaccuracy rates than the
study by Schnakers and colleagues, who showed that 40%
of the VS patients were misdiagnosed by doctors who had
not used validated behavioral test instruments [6]. That
the majority of physicians who provided a wrong diagnosis
were certain of their answer in our study, raises the ques-
tion of whether this group would perceive a need for fur-





Determining patient’s wishes (n = 320) 7 (5,9) 1
Accompanying family members in decisions (n = 322) 7 (5,8) 2
Finding long-term care (n = 314) 7 (4,9) 3
Making prognosis and predicting recovery (n = 323) 7 (4,9) 3
Evaluating resource allocation (n = 318) 7 (3,9) 4
Deciding for patient in absence of surrogate (n = 321) 7 (4,9) 4
Assessing medical futility (n = 319) 6 (3,8) 5
Making correct diagnosis (n = 325) 6 (2,8) 6
Discontinuing LST (n = 323) 6 (2,8) 6
Accompanying clients through staff rotations (n = 313) 5 (3,7) 7
Applying a decision made by surrogate (n = 318) 5 (3,7) 7
Reaching an agreement as a team (n = 320) 4 (2,6) 8
Multidisciplinary discussions for decisions (n = 321) 3 (1,5) 9
*Those who assigned the correct diagnosis to the patient in the case; Mann-Whitne
NRS (0-10).One of the most surprising findings of our study is the
high proportion of participants in Canada and Germany
who attributed capabilities to a patient in the VS akin to
misattribution of capabilities observed in the public do-
main [21] (but contra Kickman and Wegner [22]). The
key assumption underlying the traditional diagnosis of VS
is the absence of awareness [23]. However, a majority of
participants disagreed over whether the patient could per-
ceive pain, and a majority of German participants and a
large proportion of Canadian participants disagreed over
whether the patient could feel touch. These results are notg process for VS patients







Rank order p value
7 (4.5,8) 2 8 (7,10) 1 p < 0.001
6 (3,8) 4 7 (6,9) 3 p < 0.001
8 (4,9) 1 6 (4,8) 6 p = 0.007
7 (3,8) 3 8 (7,10) 1 p < 0.001
6 (3,8) 4 7 (4,9) 4 p = 0.010
5 (2,7) 6 8 (7,10) 1 p < 0.001
4 (2,7) 7 7 (5,8) 5 p < 0.001
5 (2,8) 5 7 (4,9) 4 p < 0.001
4 (2,7) 7 8 (5,10) 2 p < 0.001
5 (2,7) 6 6 (3.5,8) 7 p = 0.002
4 (2,6) 8 7 (5,8) 5 p < 0.001
3 (2,5) 10 5 (3,7) 9 p < 0.001
2 (1,4) 9 5 (3,7) 8 p < 0.001
y-U test; average rank order according to Median, 1st and 3rd quartile on
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to the medical understanding of the VS that is supported
by fMRI research [26,27]. The differences between the two
samples could be explained by the higher proportion of
participants with religious or spiritual beliefs in the
German sample given studies that have reported effects of
religious beliefs in the care of patients with disorders of
consciousness [12,13]. Another explanation might be that
more German participants provide long-term care in the
out-patient care setting and therefor might be able to ob-
serve more body expressions by patients in the VS in a re-
habilitation process that could let them assume that such
patients display capabilities inconsistent with common un-
derstandings of the diagnosis. The higher attribution of
capabilities might lead to a higher reluctance to withdraw
LST for patients in the VS.
Most Canadian participants identified long-term care
placement as the most ethically challenging issue, per-
haps because such facilities are rare in Canada. In a
qualitative study, this issue and resource allocation were
found to be important challenges in Canada [28]. Find-
ing long-term-care placement and evaluating resource
allocation were not perceived as challenging by German
participants and a potential explanation lies in a system
in which patients have greater access to long-term care
facilities such as nursing homes, specialized centers for
patients with disorders of consciousness (rehabilitation
phase F, long term care to maintain function, delivered
in specialized units), and nursing homes for patients
who require artificial respiration [29,30]. These results
are consistent with practice variations on different treat-
ment measures reported previously [7,31-33]. They also
suggest the potential impact of institutional medical
practice, health care system, legal regulations and reli-
gion, as factors influencing participants’ attitudes to-
ward treatment limitation and ethical challenges for
patients in the VS as found, for example, in large-scale
studies of LST decisions in Europe [34,35]. Although we
can only speculate on the reasons for such variation (e.
g., different culturally held moral traditions in either
country) more Canadian participants favored always
ceasing LST. One hypothesis, in line with recent re-
search on the duality of moral theories [36], is that the
attitudes of German participants, more reluctant to
withdrawal of LST, may stem from a deontological
philosophical tradition, where duties, rights and cat-
egorical principles of action have greater influence. The
more rationalistic, utilitarian responses of Canadian par-
ticipants may have led them to be more in favor of treat-
ment limitation when the prognosis is unfavorable and
chances for recovery are low. More specific data (e.g.,
on the preferred ethical theories of physicians in both
countries) would be needed to test this hypothesis. A
different explanation might link the history of seriousethical faults of the German medical profession under
the Nazi regime [37] to the expression of prudental atti-
tudes towards withdrawal of treatment for patients with
severe disabilities. Acknowledging the existence of vari-
ation and seeking a clearer understanding of its causes
are important steps to offer more coherent messages to
family members and the public and to ensure a fair
provision of treatment for patients with disorders of
consciousness.
Limitations
There was a small discrepancy in the case vignette
(modification of one word, “consistently”, in the paper
version of the Canadian questionnaire) for the sake of
improved clarity. Our analysis of the Canadian data
showed that it had no significant influence on the accur-
acy rate. Generalizability of the results of this long sur-
vey is limited by a focus on a single clinical condition
and by a low response rate, especially in Canada, but we
were able to gather representative samples of both German
neurologists and Canadian physicians based on demo-
graphic variables. Individuals most likely excluded them-
selves from participation when they did not provide care
for patients in the VS. The composition of the initial two
samples differed in age, specialties represented, experience
and physicians work setting, but the distributions of the ex-
perience with patients in the VS and gender were similar.
These constitutive differences in the two cohorts could have
influenced the described differences in the results. However,
we compared subsamples of neurologists and found no dif-
ferences in their accuracy rates. The original study design
(e.g., recruitment strategy) was the same in both countries.
Differences reported occurred because of adaptation to spe-
cific regulatory and institutional environments in the coun-
tries, such as policies of professional societies, availability of
physicians’ addresses and willingness to respond.
Conclusions
This survey of German and Canadian specialty physicians
compared their understanding of and attitudes toward the
VS. We found striking similarities in the participants’
medical knowledge with high diagnostic accuracy rates.
However, we found important differences in the attribu-
tion of capabilities to the patients and attitudes toward
limiting LST. Different hypotheses could explain this dif-
ference such as societal and medical practice contexts
(e.g., distribution of resources for the long-term-care for
these patients), religiosity, and underlying moral theories.Additional file
Additional file 1: Table S1. Circumstances justifying the limitation of
life-sustaining treatment.
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